Llwytho...
A Population Pharmacokinetic and Pharmacodynamic Model of CKD-519
CKD-519 is a selective and potent cholesteryl ester transfer protein (CETP) inhibitor that is being developed for dyslipidemia. Even though CKD-519 has shown potent CETP inhibition, the exposure of CKD-519 was highly varied, depending on food and dose. For highly variable exposure drugs, it is cruci...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Pharmaceutics |
|---|---|
| Prif Awduron: | , , , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
MDPI
2020
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7356970/ https://ncbi.nlm.nih.gov/pubmed/32575566 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/pharmaceutics12060573 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|